Turkish Translation of SportsConcussion Assesment Tool 6 (SCAT 6-tr)

August 14, 2025 updated by: FUAT YUKSEL, T.C. ORDU ÜNİVERSİTESİ

Turkish Translation And Cross-Cultural Adaptation of The Sport Concussion Assessment Tool 6th Edition (SCAT6)

Concussions, a significant type of sports injury caused by head, face, or neck trauma, are common in contact sports and require serious attention due to potential fatal consequences of mismanagement. The Sport Concussion Assessment Tool (SCAT), developed by the Concussion in Sport Group (CISG) and updated in 2023, provides a standardized approach to assess head injuries and manage athletes' return-to-sport process. While SCAT has been adapted into various languages, no Turkish version exists. This study aims to translate and culturally adapt SCAT 6 into Turkish, contributing to the accurate evaluation and management of concussion injuries among Turkish-speaking athletes.

Study Overview

Status

Active, not recruiting

Intervention / Treatment

Detailed Description

Concussions constitute an important part of sports injuries. Concussion is a head trauma caused by blows to the head, face and neck. Head injuries are common in contact sports. They are usually minor injuries. However, injuries should be taken seriously. Because mismanagement can be fatal in cases of misdiagnosis. Therefore, it is among medical emergencies .

A sports concussions group has been established for the correct management of concussions seen in sports. In 2022, the group met in Amsterdam, renewed the existing consensus and published it in the British Journal of Sports Medicine in 2023 . The Sport Concussion Assessment Tool (SCAT), developed by the sports concussion group (CISG), is a valid and reliable approach to assessing sports-related head injuries ('Sport Concussion Assessment Tool 6 (SCAT6),' 2023). The main purpose of SCAT is to assess head injuries with a standardised method and to manage the return to sport process of athletes. SCAT is an assessment tool that evaluates adult athletes over the age of 13 in terms of physical, mental and cognitive aspects and includes different sections.

In the literature, there are adaptations of previous and current versions of SCAT in different languages (Korean, Chinese, Persian, Arabic). However, no Turkish translation and adaptation study of any version has been conducted before. Turkishisation of this assessment tool is an important step in terms of accurately evaluating concussion injuries in Turkish-speaking athletes and managing the return to sport process correctly. The aim of this study is to translate the SCAT 6 into Turkish and to provide intercultural adaptation of the SCAT 6 to the literature.

Study Type

Observational

Enrollment (Estimated)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ordu, Turkey
        • Ordu University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Athletes

Description

Inclusion Criteria:

To be 13 years old

  • Talking in Turkish
  • Being a Professional Athlete

Exclusion Criteria:

  • Athletes who experience any injury during the test, retest process will be excluded from the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Lawshe Analysis
Time Frame: Before the create last verison of SCAT6-tr .It is planned to take 1 month.
The appropriateness of the assessment tool will be determined by analysing the expert opinion forms reported by the experts.
Before the create last verison of SCAT6-tr .It is planned to take 1 month.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Inter-rater reliability
Time Frame: After the last version created. It is planned to take 2 months
Scat 6-Tr will be applied randomly to 30 athletes by 2 different assessors. Scat 6-Tr will be applied randomly to 30 athletes by 2 different assessors. Inter-rater correlation will be analysed by Intra-class Correlation Coefficient (ICC).
After the last version created. It is planned to take 2 months
Test-retest reliability.
Time Frame: After the last version created. It is planned to take 2 months
SCAT6-tr will be administered to 30 athletes 2 times by the same assessor at 1 week intervals. The correlation between measurements will be evaluated with Intra-class Correlation Coefficient (ICC).
After the last version created. It is planned to take 2 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 15, 2024

Primary Completion (Estimated)

November 15, 2025

Study Completion (Estimated)

December 15, 2025

Study Registration Dates

First Submitted

December 13, 2024

First Submitted That Met QC Criteria

December 13, 2024

First Posted (Actual)

December 18, 2024

Study Record Updates

Last Update Posted (Actual)

August 19, 2025

Last Update Submitted That Met QC Criteria

August 14, 2025

Last Verified

December 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Concussion, Mild

Clinical Trials on SCAT6-tr

Subscribe